C3aR1缺失延缓白光损伤小鼠模型中的视网膜变性
研究用10,000勒克斯白光照射30分钟处理C3ar1或C5ar1敲除及野生型小鼠,4天后分析Iba1+细胞迁移、转录组和视网膜厚度。C3aR1或C5aR1全身敲除均未减轻Iba1+细胞向视网膜下间隙迁移或降低补体因子表达,但C3aR1敲除小鼠视网膜厚度部分恢复,外视网膜膜攻击复合物(MAC)沉积显著减少。作者认为C3aR1缺失通过干扰补体途径减少MAC组装来减轻视网膜变性,C3aR1靶向治疗可考虑用于干性AMD患者。
要点
- 10,000勒克斯白光照射30分钟建立小鼠视网膜变性模型,4天后评估。
- C3aR1或C5aR1敲除均未减轻Iba1+细胞向视网膜下间隙迁移。
- C3aR1敲除小鼠视网膜厚度部分恢复,外视网膜MAC沉积显著减少。
核心结论
- 作者结论为C3aR1缺失不能调节单核吞噬细胞,但通过干扰补体途径减少MAC组装而减轻视网膜变性。
- 作者认为C3aR1靶向治疗可考虑用于干性AMD患者。
研究设计与样本
- 研究对C3ar1或C5ar1敲除小鼠及野生型小鼠给予强度10,000勒克斯的白光照射30分钟。
- 光照后4天分析Iba1+细胞的转录组变化与迁移活性以及视网膜厚度。
主要发现
- C3aR1或C5aR1全身敲除均未导致Iba1+细胞向视网膜下间隙迁移减轻,也未降低光照损伤后补体因子表达(与野生型小鼠相比)。
- C3aR1敲除小鼠显示视网膜厚度部分恢复,并伴有外视网膜膜攻击复合物(MAC)出现显著减少。
临床怎么用
- 作者认为C3aR1靶向治疗可考虑用于干性AMD患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In the aging retina, persistent activation of microglia is known to play a key role in retinal degenerative diseases like age-related macular degeneration (AMD). Furthermore, dysregulation of the alternative complement pathway is generally accepted as the main driver for AMD disease progression and microglia are important producers of local complement and are equipped with complement receptors themselves. Here, we investigate the involvement of anaphylatoxin signaling, predominantly on Iba1+ cell activity, in light-induced retinal degeneration as a model for dry AMD, using anaphylatoxin receptor knockout (KO) mice. METHODS: Bright white light with an intensity of 10,000 lux was applied for 30 minutes to complement component 3a receptor 1 (C3ar1) or complement component 5a receptor 1 (C5ar1) KO and wildtype (WT) mice. Analyses of transcriptome changes and migration activity of Iba1+ cells as well as retinal thickness were performed 4 days after light exposure. RESULTS: Full body KO mice of either C3aR1 or C5aR1 were tested, but none led to mitigated migration of Iba1+ cells to the subretinal space or decreased expression of complement factors after light damage compared to WT mice. However, a partial rescue of retinal thickness was shown in C3aR1 KO mice, which was mirrored by significant less membrane attack complex (MAC) occurrence in the outer retina. CONCLUSIONS: We conclude that deletion of the anaphylatoxin receptor C3aR1 cannot modulate mononuclear phagocytes but diminishes retinal degeneration through interference with the complement pathway and thus decreased MAC assembling. C3aR1-targeted therapy may be considered for patients with dry AMD.
引用
- Behnke V, Wolf A, Hector M, et al. C3aR1-Deletion Delays Retinal Degeneration in a White-Light Damage Mouse Model. Invest Ophthalmol Vis Sci. 2025. PMID: 39775695. doi:10.1167/iovs.66.1.15
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。